Abiopharma

Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS

FDA approve FOSFOMYCIN

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

📋 Scheland Laura G. (Affiliate) plans to sell 2K shares of Oil-Dri Corporation of America (at $60.30 each, total $103K) Filed: Oct 23, 2025 | ID: 046024

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM

WILLIAMS ROBERT M JR 🔴 sold 10.0M shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $9.00 ($90.0M) Transaction Date: Oct 21, 2025 | Filing ID: 248274

VIGANO PAUL R 🔴 sold 10.0M shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $9.00 ($90.0M) Transaction Date: Oct 21, 2025 | Filing ID: 248271

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Zentek Announces Closing of Non-Brokered Private Placement of Units for Gross Proceeds of $2,479,227

Smith+Nephew PLC Notification

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

The latest from NRC Health | Reflecting on whats possible, unifying employee and patient experience, and so much more!

📋 Gibson Christopher (Officer) plans to sell 100K shares of RECURSION PHARMACEUTICALS, INC. (at $5.70 each, total $570K) Filed: Oct 23, 2025 | ID: 006529

IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting